News|Articles|December 6, 2024
The Future of Cell Therapies
Author(s)Charles River
When complexities of developing donor-derived cell therapies are considered, NGS emerges clearly as a better, cost-effective yet regulatory-compliant solution.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Transforming Clinical Bioanalysis for Manufacturing Scalability
2
Mastering Phase-Appropriate Characterization for Biologics Approval
3
A Scientifically Justified Agitation Stress Model for Early-Stage Biologics
4
From Lab to Patient: The Critical Role of Supply Chain & Distribution in the Life Sciences
5
